194 related articles for article (PubMed ID: 2452627)
1. Dual expression of the cell-surface antigens HLA-DR and CD1 (T6) by Langerhans cells in human buccal mucosa and skin.
Cruchley AT; Speight PM; Williams DM
Arch Oral Biol; 1987; 32(11):849-53. PubMed ID: 2452627
[TBL] [Abstract][Full Text] [Related]
2. Regional variation in Langerhans cell distribution and density in normal human oral mucosa determined using monoclonal antibodies against CD1, HLADR, HLADQ and HLADP.
Cruchley AT; Williams DM; Farthing PM; Lesch CA; Squier CA
J Oral Pathol Med; 1989 Oct; 18(9):510-6. PubMed ID: 2481737
[TBL] [Abstract][Full Text] [Related]
3. Defined in situ enumeration of T6 and HLA-DR expressing epidermal Langerhans cells: morphologic and methodologic aspects.
de Jong MC; Blanken R; Nanninga J; Van Voorst Vader PC; Poppema S
J Invest Dermatol; 1986 Dec; 87(6):698-702. PubMed ID: 2431069
[TBL] [Abstract][Full Text] [Related]
4. Langerhans cells expressing HLA-DQ, HLA-DR and T6 antigens in normal oral mucosa and lichen planus.
Chou MJ; Daniels TE
J Oral Pathol Med; 1989 Dec; 18(10):573-6. PubMed ID: 2621652
[TBL] [Abstract][Full Text] [Related]
5. CD-1 (T6), HLA-DR-expressing cells, presumably Langerhans cells, in nasal mucosa.
Fokkens WJ; Vroom TM; Rijntjes E; Mulder PG
Allergy; 1989 Apr; 44(3):167-72. PubMed ID: 2469344
[TBL] [Abstract][Full Text] [Related]
6. Oral mucosal Langerhans cells express DR and DQ antigens.
Walsh LJ; Seymour GJ; Savage NW
J Dent Res; 1986 Mar; 65(3):390-3. PubMed ID: 3457041
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous detection of T6 and HLA-DR antigens distinguishes three cell subpopulations in dispersed normal human epidermal cells.
Dezutter-Dambuyant C; Faure M; Schmitt D; Laquoi C; Thivolet J
Immunol Lett; 1984; 7(4):203-7. PubMed ID: 6423529
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD1 and HLA-DR by Langerhans cells (LC) in oral lichenoid drug eruptions (LDE) and idiopathic oral lichen planus (LP).
McCartan BE; Lamey PJ
J Oral Pathol Med; 1997 Apr; 26(4):176-80. PubMed ID: 9176792
[TBL] [Abstract][Full Text] [Related]
9. Human epidermal Langerhans cells cointernalize by receptor-mediated endocytosis "nonclassical" major histocompatibility complex class I molecules (T6 antigens) and class II molecules (HLA-DR antigens).
Hanau D; Fabre M; Schmitt DA; Garaud JC; Pauly G; Tongio MM; Mayer S; Cazenave JP
Proc Natl Acad Sci U S A; 1987 May; 84(9):2901-5. PubMed ID: 3106979
[TBL] [Abstract][Full Text] [Related]
10. Subclustering of CD1 monoclonal antibodies based on the reactivity on human Langerhans cells.
Schmitt D; Dezutter-Dambuyant C; Brochier J; Thivolet J
Immunol Lett; 1986 Apr; 12(4):231-5. PubMed ID: 2424832
[TBL] [Abstract][Full Text] [Related]
11. Behavior of cutaneous Langerhans' cells and skin reactivity after gold sodium thiomalate treatment of pemphigus vulgaris.
Blitstein-Willinger E
Dermatologica; 1987; 174(2):68-75. PubMed ID: 3104105
[TBL] [Abstract][Full Text] [Related]
12. Identification of Langerhans cells: simultaneous use of sera to intermediate filaments, T6 and HLA-DR antigens on oral mucosa, human epidermis and their tumours.
Löning T; Caselitz J; Seifert G; Weber K; Osborn M
Virchows Arch A Pathol Anat Histopathol; 1982; 398(2):119-28. PubMed ID: 6819705
[TBL] [Abstract][Full Text] [Related]
13. HLA-DR+/T6- Langerhans cells of the human cornea.
Seto SK; Gillette TE; Chandler JW
Invest Ophthalmol Vis Sci; 1987 Oct; 28(10):1719-22. PubMed ID: 3498703
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometrically-sorted residual HLA-DR+T6+ Langerhans cells in topical steroid-treated human skin express normal amounts of HLA-DR and CD1a/T6 antigens and exhibit normal alloantigen-presenting capacity.
Ashworth J; Kahan MC; Breathnach SM
J Invest Dermatol; 1989 Feb; 92(2):258-62. PubMed ID: 2783952
[TBL] [Abstract][Full Text] [Related]
15. Comparison between the L-DOPA histofluorescence procedure and the indirect immunofluorescence with anti-T6 and -HLA-DR monoclonal antibodies in visualizing Langerhans cells of human epidermis.
Crivellato E; Damiani D; Mallardi F
Acta Histochem; 1990; 88(1):59-64. PubMed ID: 2113342
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of T6+ and DR+ cells in human placenta.
Barthélémy H; Claudy A
Arch Dermatol Res; 1987; 279(7):495-7. PubMed ID: 3501706
[No Abstract] [Full Text] [Related]
17. Absence of Langerhans cells in oral hairy leukoplakia, an AIDS-associated lesion.
Daniels TE; Greenspan D; Greenspan JS; Lennette E; Schiødt M; Petersen V; de Souza Y
J Invest Dermatol; 1987 Aug; 89(2):178-82. PubMed ID: 3110300
[TBL] [Abstract][Full Text] [Related]
18. Langerhans' cell and vitiligo: quantitative study of T6 and HLA-DR antigen-expressing cells.
Claudy AL; Rouchouse B
Acta Derm Venereol; 1984; 64(4):334-6. PubMed ID: 6209893
[TBL] [Abstract][Full Text] [Related]
19. The activation of Langerhans cells in oral lichen planus.
Farthing PM; Matear P; Cruchley AT
J Oral Pathol Med; 1990 Feb; 19(2):81-5. PubMed ID: 1692876
[TBL] [Abstract][Full Text] [Related]
20. In cutaneous T-cell lymphoma, class II MHC molecules on CD1+ antigen-presenting cells are upregulated in involved compared with uninvolved epidermis.
Hansen ER; Bang B; Larsen JK; Vejlsgaard GL; Baadsgaard O
Br J Dermatol; 1994 Dec; 131(6):780-8. PubMed ID: 7531998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
